This document addresses the use of both computed tomography (CT) and magnetic resonance imaging (MRI) in the outpatient setting for the diagnosis, evaluation and management of brain and head-related conditions. There are many overlapping indications for MRI and CT scan. Imaging modality may depend on availability or specific individual circumstances (see Discussion section below).
Note: Please see the following related documents for additional information:
Computed Tomography
Medically Necessary
CT of the head or brain is considered medically necessary for any of the following:
A. Recent History of Head Trauma (followed by one or more of the following symptoms)
- Change in mental status or fluctuating mental status or amnesia; or
- Headache accompanied by signs of increased intracranial pressure; or
- Loss of consciousness; or
- Nausea and vomiting; or
- Neurological deficits or focal findings; or
- Seizure; or
- Skull fracture; or
- Suspected hemorrhage, or subdural or epidural hematoma; or
- Worsening headache.
B. Cerebrovascular Accident (CVA), Stroke or Transient Ischemic Attack (TIA)
- Evaluation of symptoms suggestive of stroke or TIA, such as sudden onset of weakness, focal sensory loss or speech disorder; or
- As initial imaging test to exclude hemorrhage or mass among those individuals being evaluated for possible intravenous systemic or intra-arterial thrombolysis.
C. Infection or Inflammatory Conditions (known or suspected)
- Abscess; or
- Empyema; or
- Encephalitis; or
- Meningitis; or
- Opportunistic infection associated with acquired immunodeficiency syndrome (AIDS) or other immunosuppression; or
- Parasitic disease, including neurocysticercosis.
D. Headache
CT of the head or brain in an adult is considered medically necessary for the evaluation of headache for any of the following:
- Exertional headaches; or
- Headache with fever, nuchal rigidity, nausea and vomiting or other meningeal signs; or
- Headache with new focal neurologic signs, including papilledema or visual field defects, nystagmus or gait disturbances, confusion or disorientation; or
- Headaches which awaken the individual from sleep; or
- Increased frequency or severity; or
- New onset headache at age 50 years or older with reasonable suspicion of intracranial lesion (age is a relative requirement) ; or
- New onset headache with a history of cancer or immunodeficiency; or
- Severe, sudden ('thunderclap') headache.
CT of the head or brain in children is considered medically necessary for the evaluation of headache when any of the above criteria have been met, or any of the following additional criteria have been met:
- Persistent headaches of less than 6 months duration and not responsive to medical treatment; or
- Persistent headaches without a family history of migraines; or
- Familial or personal history of disorders with predisposition to central nervous system (CNS) lesions and clinical or laboratory findings that suggest CNS involvement.
E. Malignant (primary or metastatic) and Benign Lesions (known or suspected)
- Primary intra-cranial tumors; or
- Metastatic disease; or
- Pre and post therapy evaluation of malignant lesions treated with surgery, chemotherapy, or radiation.
F. Demyelinating and Dysmyelinating Disease (e.g., multiple sclerosis, acute disseminated acute encephalomyelitis, leukodystrophies, central pontine myelinolysis and progressive multifocal leukoencephalopathy) for any of the following when MRI is not tolerated or contraindicated:
- Initial diagnosis; or
- Periodic scans to assess asymptomatic progression of multiple sclerosis during the early course of disease; or
- Tracking the progress of multiple sclerosis to establish a prognosis or evaluation of response to treatment; or
- To evaluate changes in neurologic signs and symptoms; or
- To assess for asymptomatic progression early in the course of disease if this information would be used to make treatment determinations.
G. Congenital Anomalies:
- Chiari malformation; or
- Dandy-Walker spectrum; or
- Encephalocele; or
- Holoprosencephaly; or
- Macrocephaly; or
- Microcephaly; or
- Schizencephaly; or
- Septo-optic dysplasia.
H. Vascular Abnormalities
- Aneurysm; or
- Arterio-venous malformation; or
- Cavernous malformation; or
- Cerebral vein thrombosis; or
- Dural arteriovenous fistula (DAVF); or
- Dural venous sinus thrombosis; or
- Venous hemangioma.
I. Hemorrhage or Hematoma
- Acute intra-cranial hemorrhage related to hypertensive hemorrhage or secondary to anti-coagulation or blood dyscrasia; or
- Evaluation of subacute and chronic hemorrhage when MRI is contraindicated.
J. Central Nervous System (CNS) Signs or Symptoms, evaluation of new onset or worsening of any of the following:
- Anosmia; or
- Ataxia, or loss of motor abilities, suggestive of a degenerative neurologic process; or
- Cranial nerve impairment, if MRI is contraindicated; or
- Dementia for diagnosis and evaluation of rapid progression, if MRI is contraindicated; or
- Dysguesia; or
- Endocrine abnormalities that suggest the presence of a pituitary lesion when MRI is contraindicated (including but not limited to the following):
- Growth hormone abnormalities presenting as abnormal growth velocity; or
- Abnormalities of prolactin presenting as galactorrhea and impotence or loss of libido; or
- Suspected hypogonadism; or
- Focal abnormality on neurologic exam not explained by clinical history
- Aphasia; or
- Cranial nerve impairment; or
- Diplopia; or
- Focal weakness; or
- Nystagmus; or
- Vertigo or dizziness; or
- Gait disorders; or
- Hearing loss
- Sensorineural, as work up of acoustic neuroma, when MRI is contraindicated; or
- Associated with abnormal neurologic exam or ENT exam; or
- Hydrocephalus
- Initial evaluation, if MRI is contraindicated; or
- Periodic evaluation of indwelling shunt; or
- Increased intracranial pressure or herniation; or
- Lumbar puncture, prior to, to rule out increased intracranial pressure; or
- Mental status disorders, with change or fluctuating status; or
- Movement disorders:
- Cerebellar ataxia; or
- Huntington's chorea; or
- Parkinson's disease; or
- Papilledema; or
- Paresis or paralysis; or
- Persistent tinnitus or pulsatile tinnitus; or
- Seizure disorder, new onset or increasing frequency or severity of established seizure disorder; or
- Syncope associated with abnormal neurologic findings; or
- Visual disturbances including visual field loss, diplopia or other changes unexplained by ophthalmologic history or exam.
K. Other CNS Conditions
- Development delay associated with abnormalities in the physical exam, when MRI is contraindicated; or
- Craniosynostosis; or
- Neurocutaneous disorders:
- Neurofibromatosis; or
- Sturge-Weber disease; or
- Tuberous sclerosis; or
- Von Hippel-Lindau disease.
L. Related to Neurosurgical Procedures
- As part of the pre or postoperative evaluation for craniotomy, craniofacial surgery, cranial nerve procedures or biopsy of the central nervous system
M. Other
- Abnormalities detected on other imaging studies which require additional clarification to direct treatment; or
- Ventricular shunt assessment.
Not Medically Necessary
CT of the head or brain is considered not medically necessary for any of the following:
- For the evaluation of chronic headache or migraine when there is no change in neurological status; or
- When the above criteria are not met.
Repeat imaging of the same body part by the same or similar imaging technology, when there is no change in clinical status (e.g., deterioration), persistent diagnostic problem, or medical intervention which warrants interval re-assessment is considered not medically necessary for CT head or brain except where specified above as medically necessary.
Magnetic Resonance Imaging
Medically Necessary
MRI head or brain is considered medically necessary for any of the following:
A. Recent History of Head Trauma (followed by one or more of the following symptoms)
- Change in mental status or fluctuating mental status or amnesia; or
- Headache accompanied by signs of increased intracranial pressure; or
- Loss of consciousness; or
- Nausea and vomiting; or
- Neurological deficits or focal findings; or
- Seizure; or
- Skull fracture; or
- Suspected hemorrhage, or subdural or epidural hematoma; or
- Worsening headache.
B. Cerebrovascular Accident (CVA), Stroke or Transient Ischemic Attack (TIA)
- Evaluation of symptoms suggestive of stroke or TIA, such as sudden onset of weakness, focal sensory loss or speech disorder
C. Infection or Inflammatory Conditions (known or suspected)
- Abscess; or
- Empyema; or
- Encephalitis; or
- Meningitis; or
- Opportunistic infection associated with acquired immunodeficiency syndrome (AIDS) or other immunosuppression; or
- Parasitic disease, including neurocysticercosis.
D. Headache
MRI of the head or brain in an adult is considered medically necessary for the evaluation of headache for any of the following:
- Exertional headaches; or
- Headache with fever, nuchal rigidity, nausea and vomiting or other meningeal signs; or
- Headache with new focal neurologic signs, including papilledema or visual field defects, nystagmus or gait disturbances, confusion or disorientation; or
- Headaches which awaken the individual from sleep; or
- Increased frequency or severity; or
- New onset headache at age 50 years or older with reasonable suspicion of intracranial lesion (age is relative requirement) ; or
- New onset headache with a history of cancer or immunodeficiency; or
- Severe, sudden ('thunderclap') headache.
MRI of the head or brain in children is considered medically necessary for the evaluation of headache when any of the above criteria have been met, or any of the following additional criteria have been met:
- Persistent headaches of less than 6 months duration and not responsive to medical treatment; or
- Persistent headaches without a family history of migraines; or
- Familial or personal history of disorders with predisposition to CNS lesions and clinical or laboratory findings that suggest CNS involvement.
E. Malignant (primary or metastatic) and Benign Lesions (known or suspected)
- Primary intra-cranial tumors; or
- Metastatic disease; or
- Pre and post therapy evaluation of malignant lesions treated with surgery, chemotherapy, or radiation.
F. Demyelinating and Dysmyelinating Disease (e.g., multiple sclerosis, acute disseminated acute encephalomyelitis, leukodystrophies, central pontine myelinolysis and progressive multifocal leukoencephalopathy) for any of the following:
- Initial diagnosis; or
- Periodic scans to assess asymptomatic progression of multiple sclerosis during the early course of disease; or
- Tracking the progress of multiple sclerosis to establish a prognosis or evaluation of response to treatment; or
- To evaluate changes in neurologic signs and symptoms; or
- To assess for asymptomatic progression early in the course of disease if this information would be used to make treatment determinations.
G. Congenital Anomalies
- Chiari malformation; or
- Dandy-Walker spectrum; or
- Encephalocele; or
- Holoprosencephaly; or
- Macrocephaly; or
- Microcephaly; or
- Schizencephaly; or
- Septo-optic dysplasia.
H. Vascular abnormalities
- Aneurysm; or
- Arterio-venous malformation; or
- Cavernous malformation; or
- Cerebral vein thrombosis; or
- Dural arteriovenous fistula (DAVF); or
- Dural venous sinus thrombosis; or
- Venous hemangioma.
I. Hemorrhage or Hematoma
- Acute intra-cranial hemorrhage related to hypertensive hemorrhage or secondary to anti-coagulation or blood dyscrasia when CT is contraindicated; or
- Evaluation of subacute and chronic hemorrhage.
J. Central Nervous System (CNS) Signs or Symptoms, evaluation of new onset or worsening of any of the following:
- Anosmia; or
- Ataxia, or loss of motor abilities, suggestive of a degenerative neurologic process; or
- Cranial nerve impairment; or
- Dementia for diagnosis and evaluation of rapid progression; or
- Dysguesia; or
- Encephalopathy; or
- Endocrine abnormalities that suggest the presence of a pituitary lesion:
- Growth hormone abnormalities presenting as abnormal growth velocity; or
- Abnormalities of prolactin presenting as galactorrhea and impotence or loss of libido; or
- Suspected hypogonadism; or
- Focal abnormality on neurologic exam not explained by clinical history
- Aphasia; or
- Cranial nerve impairment; or
- Diplopia; or
- Focal weakness; or
- Nystagmus; or
- Vertigo or dizziness; or
- Gait disorders; or
- Hearing loss
- Sensorineural, as work up of acoustic neuroma; or
- Associated with an abnormal neurologic exam or ENT exam; or
- Hydrocephalus
- Initial evaluation; or
- Periodic evaluation of indwelling shunt, if CT is contraindicated; or
- Mental status, objective change or fluctuation; or
- Movement disorders:
- Cerebellar ataxia; or
- Huntington's chorea; or
- Parkinson's disease;
- Papilledema; or
- Paresis or paralysis; or
- Persistent tinnitus or pulsatile tinnitus; or
- Seizure disorder, new onset or increasing frequency or severity of established seizure disorder; or
- Syncope associated with abnormal neurologic findings; or
- Vertigo and dizziness, recurrent, persistent, unexplained by other work up; or
- Visual disturbances including visual field loss, diplopia or other changes unexplained by ophthalmologic history or exam.
K. Other CNS Conditions
- Vasculitis; or
- Development delay associated with abnormalities in the physical exam; or
- Neurocutaneous disorders:
- Neurofibromatosis; or
- Sturge-Weber disease; or
- Tuberous sclerosis; or
- Von Hippel-Lindau disease; or
- Trigeminal neuralgia, atypical, or atypical facial pain; or
- Cerebral palsy, if the etiology has not been established.
L. Related to Neurosurgical Procedures:
- As part of the pre or postoperative evaluation for craniotomy, craniofacial surgery, cranial nerve procedures or biopsy of the central nervous system
M. Other
- Abnormalities detected on other imaging studies which require additional clarification to direct treatment; or
- Ventricular shunt assessment.
Not Medically Necessary
MRI of the head or brain is considered not medically necessary for any of the following:
- For the evaluation of chronic headache or migraine when there is no change in neurological status; or
- As a screening exam in asymptomatic individuals; or
- When the above criteria are not met.
Repeat imaging of the same body part by the same or similar imaging technology, when there is no change in clinical status (e.g., deterioration), persistent diagnostic problem, or medical intervention which warrants interval re-assessment is considered not medically necessary for MRI head or brain except where specified above as medically necessary.
The following codes for treatments and procedures applicable to this document are included below for informational purposes. Inclusion or exclusion of a procedure, diagnosis or device code(s) does not constitute or imply member coverage or provider reimbursement policy. Please refer to the member's contract benefits in effect at the time of service to determine coverage or non-coverage of these services as it applies to an individual member.
| CPT | |
| | CT |
| 70450 | Computed tomography, head or brain; without contrast material |
| 70460 | Computed tomography, head or brain; with contrast material(s) |
| 70470 | Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections |
| 76380 | Computed tomography, limited or localized follow-up study |
| | |
| | MRI |
| 70551 | Magnetic resonance (e.g., proton) imaging, brain (including brain stem); without contrast material |
| 70552 | Magnetic resonance (e.g., proton) imaging, brain (including brain stem); with contrast material(s) |
| 70553 | Magnetic resonance (e.g., proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences |
| | |
| | CPT/HCPCS code modifiers: |
| -26 | Professional component |
| -TC | Technical component |
| | |
| ICD-9 Diagnosis | |
| | All diagnoses |
| | |
| Discussion/General Information |
Computed tomography (CT) is a diagnostic tool that uses special x-ray equipment to obtain image data from different angles around the body, then uses computer processing of the information to show a cross-section of body tissues and organs. The CT requires less time than MRI and can be performed in acute settings where advanced monitoring and life support is needed for an unstable individual.
Magnetic resonance imaging (MRI) is a diagnostic technique that uses a cylindrical magnet and radio waves to produce high quality multiplanar images of organs and structures within the body without x-rays or radiation. The body's hydrogen atoms react to the magnetic field and pulses of radio waves. This reaction is changed to an image by a computer.
The ability of either CT or MRI to image structures in the brain and head in the indications listed above summarize the most signs, symptoms and conditions. As noted in the Clinical Indications, there are many overlapping indications for CT and MRI. Imaging modality will depend on the specific indication and individual circumstances. The following situations describe indications where there is a relative preference of one imaging technique over another.
Imaging Preference Based on Indication
General
- CT scanning is preferred for studies to identify acute hemorrhage, bony abnormalities and calcifications
- MRI is generally preferred for most other indications, including assessment of the cerebral parenchyma, cerebellum, brainstem and pituitary gland. CT is an alternative for these indications when MRI is contraindicated
Head Trauma or Hemorrhage
- CT is preferred for suspected hemorrhage, acute subdural or epidural hematoma
- MRI is preferred for suspected shearing lesions and diffuse axonal injury in closed head trauma, as well as of the subacute and chronic sequelae of head injuries
Tumors
- MRI is preferred for imaging the posterior fossa and evaluation of primary intra-axial tumors (e.g., glioblastoma, astrocytoma, lymphoma) and primary extra-axial tumors (cranial nerve tumors, e.g., acoustic neuromas) and pituitary adenomas
Cerebrovascular Accident (CVA), Stroke or Transient Ischemic Attack (TIA)
- MRI can detect a subtle mass effect that may be associated with acute bland or hemorrhagic infarction and can provide information about whether the hemorrhage is hyperacute, acute or chronic
- An MRI may be preferred to evaluate the brain stem, lacunar and deep white matter infarcts
Infection or Inflammatory Conditions
- MRI is preferred for evaluating bacterial, fungal and parasitic abscesses (e.g., cysticercosis), ventriculitis and subdural empyemas
Imaging Preferences Based on Individual Circumstances
The following are examples of specific individual characteristics that may dictate the preference of one imaging modality over another.
- The use of CT or MRI in children requires careful assessment of the risks, benefits and uses of the studies. Generally, children are more sensitive to radiation than adults and with their longer life expectancy there is a larger window of opportunity for incurring radiation damage.
- Absolute and relative contraindications for scans requiring administration of intravascular contrast material may include:
- Documented allergy from prior contrast administration or a history of atopy
- Impaired renal function, when considering an enhanced CT with intravascular iodinated contrast agents
- Multiple myeloma
- Contraindications for MRI imaging may include situations where individuals who:
- Had placement of metal devices within the body. However, for those who have small amounts of implanted metal not located in the imaging area, an open MRI may be appropriate
- Have intracranial surgical clips placed for an aneurysm that are not compatible with the use of MRI
- Have conditions requiring external devices for care (e.g., portable oxygen tank)
- Are claustrophobic; an open MRI may be appropriate
Peer Reviewed Publications:
- Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med. 2007; 357(22):2277-2284.
- Connor SE, Jarosz JM. Magnetic resonance imaging of cerebral venous sinus thrombosis. Clin Radiol. 2002; 57(6):449-461.
- Hoggard N, Wilkinson ID, Paley MN, Griffiths PD. Imaging of hemorrhagic stroke. Clin Radiol. 2002; 57(11):957-968.
- Kidwell CS, Saver JL, Villablanca JP et al. Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke. 2002; 33(1):95-98.
- Levin HS, Hanten G, Roberson G, et al. Prediction of cognitive sequelae based on abnormal computed tomography findings in children following mild traumatic brain injury. J Neurosurg Pediatrics. 2008; 1(6):461-470.
- Poser CM, Brinar VV. Diagnostic criteria for multiple sclerosis. Clin Neurol Neurosurg. 2001; 103(1):1-11.
- Rother J. CT and MRI in the diagnosis of acute stroke and their role in thrombolysis. Thromb Res. 2001; 103(Suppl 1):S125-133.
- Rubin A, Zafar, S. The assessment and management of the dizzy patient. Otolaryngol Clin North Am. 2002; 35(2):255-273.
Government Agency, Medical Society, and Other Authoritative Publications:
- American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2004; 62(6):851-863.
- American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002; 59(4):490-498.
- American Academy of Neurology; Practice Committee of the Child Neurology Society. Practice parameter: evaluation of the child with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society. Neurology. 2003; 60(3):367-380.
- American Academy of Pediatrics. Practice Guideline: The management of minor closed head injury in children. 2007. Available at http://www.aafp.org/online/en/home/clinical/clinicalrecs/headinjurychild.html. Accessed on January 4, 2010.
- American College of Radiology. ACR Appropriateness Criteria®: Available at: http://www.acr.org/SecondaryMainMenuCategories/quality_safety/app_criteria.aspx. Accessed on January 13, 2010.
- Ataxia. (2009)
- Cerebrovascular Disease. (2006)
- Dementia and Movement Disorders. (2007)
- Epilepsy. (2006)
- Focal Neurologic Deficit. (2008)
- Head trauma. (2008)
- Headache. (2009)
- Orbits, Vision and Visual Loss. (2009)
- Primary Bone Tumors. (2009)
- Soft Tissue Masses. (2009)
- Vertigo and hearing loss. (2006)
- American College of Radiology. Practice guideline: Available at: http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines.aspx. Accessed on January 13, 2010.
- Performance of computed tomography (CT) of the brain. (2006)
- Performance of computed tomography (CT) of the extracranial head and neck in adults and children. (2006)
- Performance and interpretation of magnetic resonance imaging (MRI) of the brain. (2008)
- Centers for Medicare and Medicaid Services. Available at: http://www.cms.hhs.gov/mcd/index_list.asp?list_type=ncd. Accessed on January 13, 2010.
- National Coverage Determination: Computerized Tomography. NCD# 220.1. Effective March 12, 2008.
- National Coverage Determination: Magnetic Resonance Imaging (MRI). NCD #220.2. Effective September 28, 2009.
- Frohman E, Goodin D, Calabresi P, et al. The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003; 61(5):602–611.
- Harden CL, Huff JS, Schwartz TH, et al. Reassessment: Neuroimaging in the emergency patient presenting with seizure (an evidence-based review) Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2007; 69(18):1772-1780.
- Knopman D, DeKosky S, Cummings J, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56(9):1143-1153.
- Krumholz A, Wiebe S, Gronseth G, et al. Practice Parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2007; 69(21):1996-2007.
- Lewis DW. Evaluation of children and adolescents with recurrent headaches: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002; 59(4):490-498.
- Riviello JJ, Ashwal S, Hirtz D, et al. Practice Parameter: Diagnostic assessment of the child with status epilepticus (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society Neurology. 2006; 67(9):1542-1550.
- Shevell M. Evaluation of the child with global developmental delay: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2003; 60(3):367-380.
- Silberstein S. Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55(6):754-762.
Arteriovenous Malformations
Brain
Central Nervous System
Cerebrovascular Accident (CVA)
Chiari I & II Malformations
Computed Tomography (CT)
Dementia
Head
Head Trauma
Headache
Hydrocephalus
Magnetic Resonance Imaging (MRI)
Papilledema
Pituitary Lesion
Seizure
Syncope
Vertigo
Status | Date | Action |
| Revised | 02/25/2010 | Medical Policy & Technology Assessment Committee (MPTAC) review. Addition of "when MRI is not tolerated" to CT criteria for demyelinating disease. Deletion of "craniosynostosis" from MRI criteria. Added Not Medically Necessary statements: "Repeat imaging of the same body part by the same or similar imaging technology, when there is no change in clinical status (e.g., deterioration), persistent diagnostic problem, or medical intervention which warrants interval re-assessment is considered not medically necessary for CT head or brain except where specified above as medically necessary" and "Repeat imaging of the same body part by the same or similar imaging technology, when there is no change in clinical status (e.g., deterioration), persistent diagnostic problem, or medical intervention which warrants interval re-assessment is considered not medically necessary for MRI head or brain except where specified above as medically necessary." Updated Coding, References and Websites. |
| Revised | 11/19/2009 | MPTAC review. Addition of "confusion or disorientation" to headache portion of CT and MRI head criteria, addition of "Vertigo or Dizziness" to CT and MRI head criteria, addition of "increased" to intracranial pressure or herniation for CT head criteria, addition of "or increasing frequency or severity of established seizure disorder" to CT and MRI head criteria, addition of "Abnormalities detected on other imaging studies which require additional clarification to direct treatment" to CT and MRI head criteria, addition of "Ventricular shunt assessment" to CT and MRI head criteria. Updated references and websites. |
| | 06/15/2009 | Medically necessary statements re-formatted. |
| Revised | 02/26/2009 | MPTAC review. Separated indications into categories for CT and MRI. Additions and deletions to medically necessary and not medically necessary statements. Updated references, websites, description section and discussion/general information section. Removed Place of Service section. |
| Revised | 02/21/2008 | MPTAC review. Added note regarding radiation exposure. Added pituitary adenomas to medically necessary statement for evaluation of malignant and benign lesions of the brain and head. Added clarifying information to the medically necessary statement regarding endocrine abnormalities that suggest the presence of a pituitary lesion (under section IX. Other CNS indications). Updated Coding and Reference sections. |
| Reviewed | 03/08/2007 | MPTAC review. No change to position statement; updated coding. |
| Revised | 03/23/2006 | MPTAC review. Revision based on Pre-merger Anthem and Pre-merger WellPoint Harmonization. |
| Pre-Merger Organizations | Last Review Date | Document Number | Title |
| Anthem Virginia | 07/20/2005 | | CT/MRI Brain and Head |
| WellPoint Health Networks, Inc. | 07/14/2005 | Clinical Guideline | CT/MRI Brain and Head |